Las Vegas Cannabis Testing News and More
One of the more difficult contradictions for marijuana legalization advocates to rationalize is the prohibition of medical cannabis research. The federal government labels cannabis as a Schedule 1 controlled substance which classifies marijuana as a highly addictive substance with no medical value. Yet, there has been little research permitted by the federal government that would […]
Read More
After California voters passed Prop. 64 everyone knew that marijuana possession, consumption and how cannabis would be sold would change and end up being in direct conflict with federal laws. Where federal law and state law really seem to get crossed-up the most is at the state border, in particular at airports. The most recent […]
Read More
In a recent federal ruling out of Connecticut, a judge decided that a nurse who had a job offer rescinded after testing positive for THC was discriminated against per Connecticut medical marijuana state law. The ruling is unique at the federal level as most medical marijuana consumption discrimination suits have sided with current federal laws […]
Read More
It feels like there are more research studies on marijuana to determine its medical value lately than we have ever seen before. One of the most recent studies published in JAMA Psychiatry came out of Syracuse University and sought to delve deeper into how cannabis can benefit people suffering from pain. The results of the […]
Read More
LAS VEGAS, Sept. 20, 2018 /PRNewswire/ — Digipath, Inc. (DIGP), a service-oriented independent testing laboratory and media firm focused on the developing cannabis industry, was selected by CEOLIVE Media Group for a comprehensive video interview with its President and CEO, Todd Denkin. Mr. Denkin had the opportunity to discuss Digipath’s growth in Nevada and plans for expansion into Northern California and internationally, as well as the […]
Read More
After two years of lobbying the DEA to permit marijuana imports in the form of capsules containing THC and CBD from Canada into the United States for research at the University of California San Diego’s Center for Medicinal Cannabis Research, the DEA has finally said yes. Dr. Fatta Nahab led the campaign for approval from […]
Read More
LAS VEGAS, Sept. 17, 2018 /PRNewswire/ — Digipath, Inc. (DIGP), an independent cannabis lab testing and media company, is pleased to announce the appointment of two new directors; Dr. Cindy Orser, PhD. and Mr. Bruce Raben. Dr. Orser is the Chief Science Officer (“CSO”) of Digipath’s wholly owned subsidiary, Digipath Labs, Inc. As CSO of Digipath Labs since 2014, Cindy has […]
Read More
On July 1st, California hit the reset button on its marijuana industry. While the regulated sales of adult-use cannabis started on January 1st, the state was still allowing the leftover marijuana from the system born from the 1998 Compassionate Use Act to be sold up until the July 1st deadline. Much of the marijuana in […]
Read More
It is the next logical step for the city of Las Vegas. Nevada has done nearly everything to make its largest cash cow fully capitalize on the newly legal marijuana industry. Las Vegas marijuana became available for purchase on July 1st, 2017 to any adult over the age of 21 and now Las Vegas dispensaries […]
Read More
Las Vegas marijuana sales represent the vast majority of cannabis related sales in Nevada. However, most of Nevada’s tax revenue is pumped in through Sin City anyways so that should not come as a surprise to many people. Las Vegas dispensaries surround the strip and tourists are loving it. If Vegas was not enough of […]
Read More